$1.56
0.04 (+2.89%)
DUSA Pharmaceuticals, Inc. (DUSA)
CAPS Rating:
A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.
No one has written a Pitch for DUSA stock yet. Tell us why you think DUSA will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
